Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer

Cancer Science

Volumn 102, Issue 2, 2011, Pages 330-335

  Kojima, Kensaku ^a   Hiyama, Eiso ^a,b,c   Otani, Keiko ^c   Ohtaki, Megu ^c   Fukuba, Ikuko ^c   Fukuda, Emi ^c   Sueda, Taijiro ^a,b   Hiyama, Keiko ^c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POT1 PROTEIN; RAP1 PROTEIN; TANK1 PROTEIN; TANK2 PROTEIN; TELOMERASE; TELOMERE 3' OVERHANG; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2; TIN2 PROTEIN; TPP1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; CHROMOSOME SIZE; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL SEPARATION; COLORECTAL NEOPLASMS; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE; TELOMERE-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952095525     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01786.x     Document Type: Article

References (39)

1. Moyzis R, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988; 85: 6622-6.
2. Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 1989; 17: 4611-27.
3. Watson JD. Origin of concatemeric T7 DNA. Nat New Biol (London) 1972; 239: 197-201.
4. Zhao Y, Sfeir AJ, Zou Y et al. Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells. Cell 2009; 138: 463-75.
5. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-10.
6. Liu L, Bailey SM, Okuka M et al. Telomere lengthening early in development. Nat Cell Biol 2007; 9: 1436-41.
7. Hastie ND, Dempster M, Dunlop MG et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866-8.
8. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5.
9. Piatyszek MA, Kim NW, Weinrich SL et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995; 17: 1-15.
10. Engelhardt M, Albanell J, Drullinsky P et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Clin Cancer Res 1997; 3: 1849-57.
11. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene 2002; 21: 643-9.
12. Tatsumoto N, Hiyama E, Murakami Y et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res 2000; 6: 2696-701.
13. Hiyama E, Hiyama K, Tatsumoto N et al. Telomerase activity in human intestine. Int J Oncol 1996; 9: 453-8.
14. Dukes SE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-32.
15. Koyama Y, Kotake K. Overview of colorectal cancer in Japan: report from the registry of the Japanese Society for Cancer of the Colon and Rectum. Dis Colon Rectum 1997; 40: S2-9.
16. Okuno K. Surgical treatment for digestive cancer. Current issues - colon cancer. Dig Surg 2007; 24: 108-14.
17. Hiyama E, Hiyama K, Yokoyama T et al. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992; 83: 159-64.
18. Hiyama K, Ishioka S, Shirotani Y et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995; 10: 937-44.
19. Hashimoto M, Kyo S, Masutomi K et al. Analysis of telomeric single-strand overhang length in human endometrial cancers. FEBS Lett 2005; 579: 2959-64.
20. Stewart SA, Ben-Porath I, Carey VJ et al. Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet 2003; 33: 492-6.
21. Chromczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
22. Vindeløv LL, Christensen IJ, Nissen NI. Detergent-tripsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-7.
23. Hiyama E, Yokoyama T, Hiyama K et al. Alteration of telomeric repeat length in adult and childhood solid neoplasias. Int J Oncol 1995; 6: 13-6.
24. Engelhardt M, Kumar R, Albanell J et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182-93.
25. Meeker AK, Hicks JL, Iacobuzio-Donahue CA et al. Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res 2004; 10: 3317-26.
26. De Boeck G, Forsyth RG, Praet M, Hogendoorn PC. Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms. J Pathol 2009; 217: 327-44.
27. Possemato R, Timmons JC, Bauerlein EL et al. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics. Mol Cancer Res 2008; 6: 1582-93.
28. Tang T, Zhou FX, Lei H et al. Increased expression of telomere-related proteins correlates with resistance to radiation in human laryngeal cancer cell lines. Oncol Rep 2009; 21: 1505-9.
29. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct MYB-related proteins, TRF1 and TRF2. Nat Genet 1997; 17: 231-5.
30. Kim SH, Kaminker P, Campisi J. TIN2, a new regulator of telomere length in human cells. Nat Genet 1999; 23: 405-12.
31. Smith S, Giriat I, Schmitt A, de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282: 1484-7.
32. O'Connor MS, Safari A, Liu D et al. The human Rap1 protein complex and modulation of telomere length. J Biol Chem 2004; 279: 28585-91.
33. Yamada M, Tsuji N, Nakamura M et al. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 2002; 22: 3303-7.
34. Wang F, Podell ER, Zaug AJ et al. The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 2007; 445: 506-10.
35. Xin H, Liu D, Wan M et al. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 2007; 445: 559-62.
36. Kondo T, Oue N, Yoshida K et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004; 64: 523-9.
37. Li B, de Lange T. Rap1 affects the length and heterogeneity of human telomeres. Mol Biol Cell 2003; 14: 5060-8.
38. Miller KM, Ferreira MG, Cooper JP. Taz1, Rap1 and Rif1 act both interdependently and independently to maintain telomeres. EMBO J 2005; 24: 3128-35.
39. Hsu CP, Ko JL, Shai SE, Lee LW. Modulation of telomere shelterin by TRF1 and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer. Lung Cancer 2007; 58: 310-6.